Gilead Sciences

Investigational Seladelpar Demonstrates Significant Improvements in Liver Disease Progression and Reduced Itching in Primary Biliary Cholangitis

18 May 2024

Investigational Seladelpar Demonstrates Significant Improvements in Liver Disease Progression and Reduced Itching in Primary Biliary Cholangitis

Kite Data at EHA 2024 Demonstrate Positive Patient Outcomes and Advances in Delivery of CAR T-cell Therapy

14 May 2024

Kite Data at EHA 2024 Demonstrate Positive Patient Outcomes and Advances in Delivery of CAR T-cell Therapy

Kite and Arcellx Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program

10 May 2024

Kite and Arcellx Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program

Gilead and Kite Oncology to Highlight Broad and Diverse Oncology Portfolio at ASCO 2024

07 May 2024

Gilead and Kite Oncology to Highlight Broad and Diverse Oncology Portfolio at ASCO 2024

FDA Approves Biktarvy® Label Update With Data for Pregnant Adults With HIV

26 Apr 2024

FDA Approves Biktarvy® Label Update With Data for Pregnant Adults With HIV

Gilead Sciences Announces First Quarter 2024 Financial Results

26 Apr 2024

Gilead Sciences Announces First Quarter 2024 Financial Results

Gilead Sciences to Release First Quarter 2024 Financial Results on Thursday, April 25, 2024

10 Apr 2024

Gilead Sciences to Release First Quarter 2024 Financial Results on Thursday, April 25, 2024

FDA Expands Indication for Gilead's Vemlidy (Tenofovir Alafenamide) to Treat Chronic HBV Infection in Pediatric Patients as Young as Six

28 Mar 2024

FDA Expands Indication for Gilead's Vemlidy (Tenofovir Alafenamide) to Treat Chronic HBV Infection in Pediatric Patients as Young as Six

Gilead and Xilio Announce Exclusive License Agreement for Tumor-Activated IL-12 Program

28 Mar 2024

Gilead and Xilio Announce Exclusive License Agreement for Tumor-Activated IL-12 Program

Gilead Sciences Announces Completion of Acquisition of CymaBay

22 Mar 2024

Gilead Sciences Announces Completion of Acquisition of CymaBay